Ensuring Compliance and Operational Accuracy: How a Renowned Pharma Client Streamlined Qualification and Access Control with Discus QMS

Client Overview

Fremed Pharmaceuticals, a growing name in the pharmaceutical and life sciences industry, is known for its commitment to producing high-quality, compliant, and patient-focused healthcare solutions. Operating in a highly regulated environment, Fremed is expected to meet stringent quality assurance protocols such as cGMP, FDA 21 CFR Part 11, and GAMP 5 validation standards. As the organization scaled its operations, ensuring digital compliance and system validation became a top priority.

Challenges Faced

As Fremed expanded, it encountered key operational challenges that could compromise compliance and hinder efficiency:

• Lack of Validation Readiness: Operation Qualification (OQ) documents required a thorough review and validation. Incomplete or inaccurate documentation posed risks during audits and inspections.
  
  
• EDC Form Gaps: The Electronic Data Capture (EDC) forms lacked consistency and completeness, affecting data traceability and clinical workflow alignment.
  
  
• Unstructured Access Controls: Role-based access was not properly aligned with SOPs, creating potential compliance and security risks.
  
  
• No Unified Validation Plan: There was no centralized validation activity framework in place to ensure the system's regulatory readiness before going live.

These challenges, if left unaddressed, would impact audit preparedness, internal accountability, and overall process efficiency.

‍

The Discus QMS Solution

To solve these issues, Discus IT Pvt. Ltd. deployed its industry-leading Discus QMS platform, specifically tailored for the pharmaceutical industry. Here's how we addressed Fremed's needs:

1. OQ Document Review

We collaborated closely with the QA and validation teams to review Operation Qualification documents. Our team ensured every document was accurate, complete, and ready for audit submission, reinforcing regulatory alignment from day one.

2. EDC Form Validation

All EDC forms were reviewed, validated, and corrected as per compliance protocols. The Discus team supported Fremed in ensuring every record was traceable, complete, and audit-ready.

3. Roles & Permission Setup

We created user roles and assigned permissions based on Fremed’s SOPs. This minimized unauthorized access and brought the system’s access management in line with best practices and regulatory standards.

4. Validation Activity Plan & Go-Live

A joint effort with the GAMP and Fremed teams helped establish a robust Validation Activity Plan. The system went live successfully within the scheduled timeline, with zero compliance deviations.

Configuration & Customization

Discus QMS was configured to:

• Support SOP-driven role hierarchies
  
  
• Enable real-time document validation workflows
  
  
• Automate form reviews and approval trails
  
  
• Align with pharma industry regulations and Fremed’s internal compliance structure

No third-party integrations were required, allowing for a secure, standalone system customized to the client's needs.

Conclusion

With Discus QMS, Fremed Pharmaceuticals transitioned from a fragmented document and validation process to a fully streamlined, audit-ready digital environment. From document reviews and EDC validation to SOP-based access control and on-time go-live, the transformation reinforced the company’s commitment to compliance, quality, and operational excellence.

Discus IT Pvt. Ltd. remains a trusted partner for regulated industries seeking scalable, validated, and secure QMS solutions.

‍